The Discounted Cash Flow (DCF) valuation of Amneal Pharmaceuticals Inc (AMRX) is 13.45 USD. With the latest stock price at 12.88 USD, the upside of Amneal Pharmaceuticals Inc based on DCF is 4.4%.
Based on the latest price of 12.88 USD and our DCF valuation, Amneal Pharmaceuticals Inc (AMRX) is a buy. buying Amneal stocks now will result in a potential gain of 4.4%.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 9.4% | 7.9% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 6.01 - 41.59 | 13.45 |
| Upside | -53.3% - 222.9% | 4.4% |